MPALs with recurrent cytogenetic abnormalities (BCR-ABL1 and KMT2A rearrangements) represent distinct entities in the last WHO classification; MPALs without these anomalies have been termed MPAL B/myeloid and T/myeloid NOS. Here, KMT2A is linked to mixed phenotype acute leukemia.